| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026065568 |
| P356 | DOI | 10.1007/S00296-006-0145-0 |
| P698 | PubMed publication ID | 16770616 |
| P50 | author | Mesut Ogrendik | Q79930740 |
| P2860 | cites work | Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis | Q24672292 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate | Q28295474 | ||
| Cytokines in periodontal disease: where to from here? | Q34335167 | ||
| Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis? | Q34618168 | ||
| Immunoglobulin G and A Antibody Responses toBacteroides forsythusandPrevotella intermediain Sera and Synovial Fluids of Arthritis Patients | Q37057615 | ||
| Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain | Q38307134 | ||
| Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytoki | Q39806745 | ||
| Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system. | Q40277409 | ||
| Self-heat shock protein 60 induces tumour necrosis factor-alpha in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease | Q40746498 | ||
| The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials | Q40914450 | ||
| Heat shock proteins in the human periodontal disease process | Q41496880 | ||
| Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine | Q41918654 | ||
| The antibacterial effects of ornidazole on primary molars with infected pulps | Q43578379 | ||
| Anti-anaerobic antibacterial agents | Q44438287 | ||
| American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 | ||
| Relationship between rheumatoid arthritis and periodontitis | Q49192929 | ||
| Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria. | Q54568340 | ||
| Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. | Q54624294 | ||
| Rheumatoid factor (RF) distribution in periodontal disease | Q67970600 | ||
| Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial | Q69892485 | ||
| Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum | Q70483087 | ||
| The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales | Q70606503 | ||
| Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire | Q71095022 | ||
| Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors | Q72095802 | ||
| Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories | Q72192464 | ||
| Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study | Q72658167 | ||
| Rheumatoid factor from periodontitis patients cross-reacts with epitopes on oral bacteria | Q73387335 | ||
| Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein | Q73502940 | ||
| Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis | Q73674564 | ||
| Epitope mapping of heat shock protein 60 (GroEL) from Porphyromonas gingivalis | Q73920119 | ||
| Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? | Q77341371 | ||
| Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies) | Q78139394 | ||
| P433 | issue | 12 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| placebo | Q269829 | ||
| P304 | page(s) | 1132-1137 | |
| P577 | publication date | 2006-06-13 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study | |
| P478 | volume | 26 |
Search more.